Emyria Reports Promising 3-Month PTSD Treatment Results
Filed with ASX · · 6 pages · English
In the deck
Story so far
Earlier from Emyria
- December 2024 Quarterly Activities Report and Appendix 4C
- Leadership Updates
- Emyria Secures $2.525M in Strongly Supported Placement
- Response to ASX Price Query
- Emyria & UWA Partner to License Novel Serotonin Therapies
Later from Emyria
- Emyria Opens New Empax Centre to Meet Demand and Payer Needs
- March 2025 Quarterly Activities Report and Appendix 4C
- PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU
- Medibank to Fund Emyria's PTSD Program at Perth Clinic
- Largest Australian Health Insurer to Fund Innovative PTSD Treatment Program
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria